Biotricity, Inc. announced on May 2, Stephen Salmon a member of the Board of Directors of company and the Company's Compensation Committee, resigned from the Company's Board of Directors effective May 2, 2022. On May 4, 2022, the Board of Directors of the Company appointed Ronald McClurg to the Board of Directors to fill the vacancy created by Mr. Salmon's resignation. There are no arrangements or understandings between Mr. McClurg and any other persons pursuant to which he was selected as a director, Mr. McClurg will receive compensation as a non-employee director in accordance with the company's non-employee director compensation practice.

Mr. McClurg is a senior financial executive with experience leading the finance, administrative and IT functions in private and public companies. From 2003 to 2019, Mr. McClurg was the Vice President, Finance & Administration and Chief Financial Officer for Incisive Surgical, Inc. Since 2020 Mr. McClurg has been a consultant.